Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Ceftriaxone
Therapeutic Area : Undisclosed
Study Phase : Phase I
Recipient : University of Oxford
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Compare Blood Levels of Ceftriaxone Given by Suppository or Injection.
Details : Ceftriaxone is a Antibiotic drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
March 29, 2019
Lead Product(s) : Ceftriaxone
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Recipient : University of Oxford
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
